DOMZALSKI DAVID (President and CEO) reported 1 transaction at VYNE THERAPEUTICS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/2/2025ACC: 0001415889-25-009629
DirectorOfficer· President and CEO
Since Mar 2020
-30.50K
Net shares
Net seller
$48.2K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
30.50K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−30.50K
Price / share
$1.58
Trade value
$48.19K
% of position
6.4%
3/31/2025
476.06K→445.56K
Total
Net shares
−30.50K
Net value
-$48.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/31/2025 | F · Tax Withholding | −30.50K | $1.58 | $48.19K | 6.4% | 476.06K | 445.56K |
| Total | −30.50K | -$48.19K | ||||||
Derivative Transactions0
No derivative transactions reported